The company has raised the sum of $4.6 million in its latest funding round and plans on using this fund to fuel its plans of bringing theoretical drug molecules to life. The company’s machine learning systems operate by predicting the most suitable and viable ways of synthesizing potentially valuable molecules which is an important part of creating new drugs and treatments for diseases.
The company was part of the Disrupt SF 2019 Startup Battlefield. It was on this platform that Molecule.one described the challenges that the drug discovery industry is faced with. The company explained that many companies in the drug discovery industry can come up with treatments in theory but are faced with the challenge of making the molecules.
Now this is how Molecule.one works! When there is a new compound that probably no one has enough knowledge about that needs to be made and tested, this is where the company’s machine learning systems come in. The company works by creating a workflow that starts with everyday chemicals and provides step-by-step guidelines using already established methods to transcend from one point to another, and another.
The company’s CSO – Stanislaw Jastrzebski explained that the company leverages machine learning and vast knowledge of already established chemical reactions to create a process. “Synthetic planning can be characterized as a game. In each move of this game, instead of moving a piece on a board, we break a chemical bond between a pair of atoms. The goal of the game is to break down a target molecule to molecules that can then be bought on the market and used to synthesize the target. We use algorithms similar to the ones used by DeepMind to master Go or chess to find the synthetic pathway”, he explained.
Startups like Molecule.one gives hope to the future of medicine.
Ibhadojemu Lucky Emmanuel is a graduate of Education and Economics from the University of Benin. He has a passion for tech and business and has been writing professionally for over a period of five years. He's written across various topics and segments and knew tech-business was it when he first stumbled on it. He has a great passion for music and arts, and wants to visit as many countries as he can someday.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
